Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

WHO calls for emergency action to halt TB in Africa

WHO calls for urgent and extra ordinary actions in Africa to halt spread od TB epidemic.



31 August, 2005: Declaring TB an emergency in African region, the World Health Organization (WHO) Regional Committee for Africa comprising health ministers from 46 Member States has called for "urgent and extraordinary actions'' to halt worsening epidemic.

The epidemic that has more than quadrupled the annual number of new TB cases in most African countries since 1990 and is continuing to rise across the continent, killing more than half a million people every year.

The declaration was made in a resolution adopted today at the end of the Committee's fifty-fifth session in Maputo, Mozambique. The resolution urges Member States in the African Region to commit more human and financial resources to strengthen DOTS programmes and scale up collaborative interventions to fight the co-epidemic of TB and HIV. These and other measures recommended by the Committee encompass those laid out in a "blueprint" developed by the global Stop TB Partnership, which calls for US $2.2 billion in new funding for TB control in Africa during 2006-2007.

"Despite commendable efforts by countries and partners to control tuberculosis, impact on incidence has not been significant and the epidemic has now reached unprecedented proportions,'' said WHO Regional Director for Africa, Dr Luis Gomes Sambo in a WHO release. ``Urgent and extraordinary actions must be taken, or else the situation will only get worse and the TB targets in the Abuja Declaration and the Millennium Development Goals will not be achieved."

Globally, TB is second only to HIV/AIDS as a cause of illness and death of adults, accounting for nearly nine million cases of active disease and two million deaths every year. Although it has only 11% of the world's population, Africa accounts today for more than a quarter of this global burden with an estimated 2.4 million TB cases and 540,000 TB deaths annually.

In the late 1970s and early 1980s, African countries like Tanzania, Mozambique and Malawi were among the first to apply what became the global TB control strategy now known as DOTS. But in the past 15 years, TB incidence rates have soared in the region - to as high as four-fold in Malawi and five-fold in Kenya, to cite some typical examples -due largely to the link with HIV/AIDS, poverty and weak health systems. Although countries have made efforts to treat the rising tide of TB cases, they are still being outpaced by the epidemic.

"It is tragic that this disease has not been brought under control, because I am living proof that TB can be effectively treated and cured," said Nobel laureate Archbishop Desmond Tutu, who along with former South African President Nelson Mandela is a survivor of the disease. "The problem is huge and medical authorities cannot overcome it alone, they need help. A full course of TB drugs that costs 15 dollars will save the lives of TB patients - and in the case of people who are co-infected with HIV, extend their lives by precious years until ARVs become more widely available in Africa."

Among the constraints to fighting the epidemic cited in the Maputo meeting is the inadequate financial support currently available for TB control. A large majority of African countries that provided financial data to WHO in 2003 reported funding gaps, including eight of the nine countries with the highest TB burden. Many national TB programmes are relying extensively on grants from external donor agencies, including the Global Fund to Fight AIDS, TB and Malaria (GFATM). At the same time, few African countries have included TB in their poverty alleviation strategies.

But more financial resources alone will not solve the TB problem. Dedicated efforts must also be made to strengthen health systems and respond to the crisis of health workforce attrition in the region. The specific actions called for by the Regional Committee to address the TB emergency are:
  • Improve the quantity and quality of staff involved in TB control; 
  • Rapidly improve TB case detection and treatment success rates with expanded DOTS coverage at national and district levels; 
  • Reduce the combined TB patient default and transfer out rates to 10% or less; 
  • Scale up interventions to manage TB and HIV together, including increased access to anti-retroviral therapy for TB patients who are co-infected with HIV, and to chemoprophylaxis against TB for people with HIV; 
  • Expand national TB partnerships, public-private collaboration and community participation in TB control activities. 

In the other four WHO regions of the world, TB trends are either stable or in decline and are on track to reach the MDG targets of halving TB prevalence and deaths by 2015, the release said.


Pharma News Headlines

Cancer News

Cardiac News


Pharma industry news

Diseases - Alzheimer's, Parkisonson's and Obesity

Contraception and Abortion News


Anti fungal terbinafine launched in Europe: Actavis

HIV entry blocking drug data encouraging: Progenics

Allegra generic to be launched in US

Long-acting pain drug data positive: Pain Therapeutics

New kidney cancer drug seeks EU nod

Inhaled insulin may get US FDA clearance

A vaccine against fungus is on way

Enzyme stops progression of HIV in survivors, confirms study

Aclasta found faster-acting in Paget's disease treatment

Beta blocker can start therapy in heart failure: Merck

Halobetasol generic launched in US

Anemia drug darbepoetin's late-stage studies begin: Amgen

Cholesterol generic gets marketing nod in US: Par

Aricept for severe Alzheimer’s disease too: Eisai

Bone regeneration trials begin in US:Mesoblast

New dye to detect early Alzheimer's

Breast forming gene discovered

Thyroid drug to be supplied by IVAX in US

Rituxan, cancer drug can treat rheumatoid arthritis

Yasminelle, low-dose oral contraceptive approved in the Netherlands

Fluarix, anti-flu shot by Glaxo approved

Increlex, drug to treat `abnormally short’ kids approved in US

Anti-HIV drugs prices cut: Gilead

US FDA approves Takeda’s drug combo for type 2 diabetes

Novartis’ drug for breast cancer recurrence to be given priority review in US

US puts off decision on contraceptive pill again

Shire’s ADHD drug Adderall back on list in Canada

WHO calls for emergency action to halt TB in Africa

Some of the Vioxx suits may be settled: Merck

Nasdaq delists Able on bankruptcy filing

Hospira ships ceftriaxone generics to US

Renovis stops sciatica drug studies

Merck sets up generic arm Genpharm in US

Morning after pills still not within easy reach in US

New cancer combo therapy results positive:OXiGENE

Aceon approved for heart disease treatment in US

Cell Therapeutics to seek approval for lung cancer therapy in US and Europe

Anti-depressant Seroxat defended by GSK against new findings

Vioxx verdict: Merck’s defeat to trigger thousands of lawsuits from US, UK

Aspirin stops colon cancer, but may trigger bleeding

New blood test method approved in US

Skin disease drug turns into anti-tumor therapy for cancer

Step-by-Step instructions for dealing with Asthma Attacks

Potential Alzheimer's Disease drugs under investigation

New Molecule may help obese lose weight

Paxil (Paroxetine) may heighten suicide risks, finds study

"Breast cancer chances higher due to fried chips"

Safety alert on Gambro Dasco’s Prisma renal system

Merck responsible for Vioxx death: Jury

Heart disease deaths more among New Yorkers

Pfizer to offer drugs risk/benefit summary to consumers 

Merck lied to public on Vioxx: lawyer tells jurors

Novartis acquires rights of kidney dialysis drug from SeBo

J&J's Concerta approved treatment of ADHD in teenagers in Canada

US FDA stalls Roche’ Accutane use in pregnancy

Novo Nordisk, Eli Lilly remove insulin products from Australia

British drug supply chain safety questioned after another fake Lipitor find

Wyeth starts support programme for Effexor patients

P&G’s Actonel with Calcium approved for osteoporosis

Pozen gets patent on pain management product

Genmab studies new drug for rheumatoid arthritis

Painkillers may increase blood pressure: study

Nektar buys out Aerogen for $32 m

Predix records positive data on anxiety drug

Insmed files against Increlex approval

Hepatitis A vaccine for kids approved in US

Psoriasis drug data positive: Cytochroma

Novo Nordisk’s 24-hour acting insulin Levemir gets US FDA okay

US FDA approves Teva's generic for osteoporosis 


Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us